Home / Inspections / 1160701

FDA Inspection 1160701 — Reese Pharmaceutical Company

Reese Pharmaceutical Company — FEI 1518939

The FDA completed an inspection of Reese Pharmaceutical Company on December 8, 2021 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 8, 2021
Fiscal Year
2022
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Cleveland, OH (United States)

Facility

Other inspections at this facility

  • 1287906 (NAI Thu Sep 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1160702 (NAI Thu Dec 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017672 (NAI Mon Jun 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012578 (NAI Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 758639 (VAI Wed Jan 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources